| Financial Year |
March 31 2023 |
| Monetary Funds |
677,394,093.81 |
| Held-for-trading Financial Assets |
308,899,668.81 |
| Notes Receivable |
-- |
| Accounts Receivable |
151,742,630.92 |
| Advances to Suppliers |
18,105,336.70 |
| Other Receivables |
32,839,142.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
648,072,367.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
75,218,918.22 |
| Total Current Assets |
1,924,253,063.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
301,706,447.43 |
| Investment Properties |
1,287,067.43 |
| Fixed Assetes |
1,250,877,425.99 |
| Under-construction Projects |
561,771,403.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
140,622,534.51 |
| R&D expenses |
30,784,190.25 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
18,162,851.50 |
| Deferred Income Tax Assets |
111,654,011.03 |
| Other Non-Current Assets |
52,879,405.50 |
| Sub-Total of Non-Current Assets |
2,503,228,023.25 |
| Total Assets |
4,427,481,086.30 |
| Short-Term Loans |
478,158,500.00 |
| Trading Financial liabilities |
7,279,441.62 |
| Notes Payable |
185,629,296.43 |
| Accounts Payable |
279,799,723.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,895,691.28 |
| Taxes Payable |
88,414,388.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,851,697.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
54,999,397.23 |
| Other Current Liabilities |
3,782,566.03 |
| Sub-Total of Current Liabilities |
1,327,804,909.70 |
| Long-term Loans |
245,000,000.00 |
| Bonds Payable |
419,683,617.13 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
100,371,228.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
871,099,350.25 |
| Total Liabilities |
2,198,904,259.95 |
| Paid-In Capital(Or Share Stock) |
213,401,060.00 |
| Capital Surplus |
568,889,934.74 |
| Surplus Reserve |
36,293,172.24 |
| LESS:Treasury Stock |
30,869,031.82 |
| Undistributed Profits |
1,277,768,347.48 |
| Minority Stockholder's Interest |
91,083,830.08 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,137,492,996.27 |
| Owner's Equity（Stockholder's Equity） |
2,228,576,826.35 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,427,481,086.30 |
